Jiangsu Recbio (2179) Announces H Share Full Circulation Listing Approval

Bulletin Express02-06 19:42

Jiangsu Recbio Technology Co., Ltd. (stock code: 2179) announced that it received listing approval from The Stock Exchange of Hong Kong Limited on February 5, 2026 for converting 141,953,489 unlisted shares into H shares. This development follows the earlier disclosures on May 21, 2025 and January 30, 2026 regarding the proposed participation in H Share Full Circulation.

A total of 28 shareholders participate in the conversion, covering 141,953,489 shares. Following completion of the conversion and listing procedures, Jiangsu Recbio’s overall share count remains 626,075,702 shares. The proportion of domestic shares decreases from 47.59% to 26.83%, while the portion of H shares rises from 50.50% to 73.17%.

Jiangsu Recbio will proceed with the relevant conversion and trading procedures for the newly converted H shares. Market participants are advised to monitor official company announcements for developments regarding the timeline and completion of the listing process.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1135343398?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-06 19:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1135343398","market":"hk","top_or_hot":-1,"title":"Jiangsu Recbio (2179) Announces H Share Full Circulation Listing Approval","media":"Bulletin Express","content":"<p>Jiangsu Recbio Technology Co., Ltd. (stock code: 2179) announced that it received listing approval from The Stock Exchange of Hong Kong Limited on February 5, 2026 for converting 141,953,489 unlisted shares into H shares. This development follows the earlier disclosures on May 21, 2025 and January 30, 2026 regarding the proposed participation in H Share Full Circulation.</p>\n<p>A total of 28 shareholders participate in the conversion, covering 141,953,489 shares. Following completion of the conversion and listing procedures, Jiangsu Recbio’s overall share count remains 626,075,702 shares. The proportion of domestic shares decreases from 47.59% to 26.83%, while the portion of H shares rises from 50.50% to 73.17%.</p>\n<p>Jiangsu Recbio will proceed with the relevant conversion and trading procedures for the newly converted H shares. Market participants are advised to monitor official company announcements for developments regarding the timeline and completion of the listing process.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jiangsu Recbio (2179) Announces H Share Full Circulation Listing Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJiangsu Recbio (2179) Announces H Share Full Circulation Listing Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-06 19:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jiangsu Recbio Technology Co., Ltd. (stock code: 2179) announced that it received listing approval from The Stock Exchange of Hong Kong Limited on February 5, 2026 for converting 141,953,489 unlisted shares into H shares. This development follows the earlier disclosures on May 21, 2025 and January 30, 2026 regarding the proposed participation in H Share Full Circulation.</p>\n<p>A total of 28 shareholders participate in the conversion, covering 141,953,489 shares. Following completion of the conversion and listing procedures, Jiangsu Recbio’s overall share count remains 626,075,702 shares. The proportion of domestic shares decreases from 47.59% to 26.83%, while the portion of H shares rises from 50.50% to 73.17%.</p>\n<p>Jiangsu Recbio will proceed with the relevant conversion and trading procedures for the newly converted H shares. Market participants are advised to monitor official company announcements for developments regarding the timeline and completion of the listing process.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02179","symbol_name":"瑞科生物-B","start_time":0,"source_url":"","article_id":"1135343398","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1135343398","pubTimestamp":1770378146,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jiangsu Recbio Technology Co., Ltd. (stock code: 2179) announced that it received listing approval from The Stock Exchange of Hong Kong Limited on February 5, 2026 for converting 141,953,489 unlisted...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02179":"瑞科生物-B"},"translate_title":"江苏瑞生物(2179)公布H股全流通上市批准","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02179":1},"content_text":"Jiangsu Recbio Technology Co., Ltd. (stock code: 2179) announced that it received listing approval from The Stock Exchange of Hong Kong Limited on February 5, 2026 for converting 141,953,489 unlisted shares into H shares. This development follows the earlier disclosures on May 21, 2025 and January 30, 2026 regarding the proposed participation in H Share Full Circulation.\nA total of 28 shareholders participate in the conversion, covering 141,953,489 shares. Following completion of the conversion and listing procedures, Jiangsu Recbio’s overall share count remains 626,075,702 shares. The proportion of domestic shares decreases from 47.59% to 26.83%, while the portion of H shares rises from 50.50% to 73.17%.\nJiangsu Recbio will proceed with the relevant conversion and trading procedures for the newly converted H shares. Market participants are advised to monitor official company announcements for developments regarding the timeline and completion of the listing process.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1135343398","isCrawlerRequest":true}